No way [Dissolution / BCS / IVIVC]

posted by yuvaneshwari – India, 2019-01-28 05:16 (672 d 06:24 ago) – Posting: # 19815
Views: 1,566

Thanks for your response. I was hoping to justify the waiver on the basis of sameness of finished test product against reference. I understand that criticality still remain since the molecule is BCS II drug. Thank you.


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe]

Complete thread:

Activity
 Admin contact
21,223 posts in 4,427 threads, 1,481 registered users;
online 18 (1 registered, 17 guests [including 13 identified bots]).
Forum time: Monday 11:40 CET (Europe/Vienna)

It’s difficult to work in a group
when you are omnipotent.    John de Lancie (as Q)

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5